Intraductal Papillary Neoplasm of the Bile Duct

Intraductal Papillary Neoplasm of the Bile Duct — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	352	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	158	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Preceding 5-year window	2020-09-11 → 2025-09-10	138	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2020/09/11:2025/09/10[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	35	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed
y2016	2016-01-01 → 2016-12-31	20	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-11	pubmed
y2017	2017-01-01 → 2017-12-31	22	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-11	pubmed
y2018	2018-01-01 → 2018-12-31	26	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-11	pubmed
y2019	2019-01-01 → 2019-12-31	32	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-11	pubmed
y2020	2020-01-01 → 2020-12-31	30	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-11	pubmed
y2021	2021-01-01 → 2021-12-31	30	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-11	pubmed
y2022	2022-01-01 → 2022-12-31	29	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-11	pubmed
y2023	2023-01-01 → 2023-12-31	35	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-11	pubmed
y2024	2024-01-01 → 2024-12-31	32	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-11	pubmed
y2025	2025-01-01 → 2025-12-31	30	`("Intraductal Papillary Neoplasm of the Bile Duct"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (29)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 29 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
· Lancet Oncol · 2020 · PMID 32416072 · validated civic_curation pubmed
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
· Lancet Oncol · 2020 · PMID 32203698 · validated civic_curation pubmed
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
· Lancet Gastroenterol Hepatol · 2021 · PMID 34358484 · validated civic_curation pubmed